Claimtra
PrivateLast Round
Seed Round
May 13, 2026
Est. Valuation
$1.5M
Total Funding Raised
$25,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Claimtra is a healthtech company that provides an AI-powered claims analytics platform to help hospitals recover revenue from denied or underpaid insurance claims.
Sector
Enterprise Software
Verticals
Revenue Cycle, Vertical SaaS, Healthcare Analytics, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Claimtra Comparables
Compare Claimtra with similar companies based on industry and business-model similarity.
Claimtra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 13, 2026 | ||||
| Accelerator | Oct 17, 2025 |
Claimtra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mississippi Angel Investor Network | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$50K seed round completed.
- Oct 17, 2025
$25K round led by CoBuilders
Claimtra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Claimtra's valuation, stock price, and market status.